Neoantimon: a multifunctional R package for identification of tumor-specific neoantigens.

Bioinformatics

Division of Health Medical Data Science, Health Intelligence Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.

Published: September 2020


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Summary: It is known that some mutant peptides, such as those resulting from missense mutations and frameshift insertions, can bind to the major histocompatibility complex and be presented to antitumor T cells on the surface of a tumor cell. These peptides are termed neoantigen, and it is important to understand this process for cancer immunotherapy. Here, we introduce an R package termed Neoantimon that can predict a list of potential neoantigens from a variety of mutations, which include not only somatic point mutations but insertions, deletions and structural variants. Beyond the existing applications, Neoantimon is capable of attaching and reflecting several additional information, e.g. wild-type binding capability, allele specific RNA expression levels, single nucleotide polymorphism information and combinations of mutations to filter out infeasible peptides as neoantigen.

Availability And Implementation: The R package is available at http://github/hase62/Neoantimon.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750962PMC
http://dx.doi.org/10.1093/bioinformatics/btaa616DOI Listing

Publication Analysis

Top Keywords

neoantimon multifunctional
4
multifunctional package
4
package identification
4
identification tumor-specific
4
tumor-specific neoantigens
4
neoantigens summary
4
summary mutant
4
mutant peptides
4
peptides missense
4
mutations
4

Similar Publications

Neoantimon: a multifunctional R package for identification of tumor-specific neoantigens.

Bioinformatics

September 2020

Division of Health Medical Data Science, Health Intelligence Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.

Summary: It is known that some mutant peptides, such as those resulting from missense mutations and frameshift insertions, can bind to the major histocompatibility complex and be presented to antitumor T cells on the surface of a tumor cell. These peptides are termed neoantigen, and it is important to understand this process for cancer immunotherapy. Here, we introduce an R package termed Neoantimon that can predict a list of potential neoantigens from a variety of mutations, which include not only somatic point mutations but insertions, deletions and structural variants.

View Article and Find Full Text PDF